Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Cells|December 24, 2021
Inhibition of O-GlcNAc Transferase Alters the Differentiation and Maturation Process of Human Monocyte Derived Dendritic CellsMatjaž Weiss, Marko Anderluh, Martina GobecCurrent Medicinal Chemistry|September 25, 2013
Isoform selective voltage-gated sodium channel modulators and the therapy of painMarko Jukič, Danijel Kikelj, Marko AnderluhJournal of Molecular Modeling|June 5, 2015
Comparative evaluation of several docking tools for docking small molecule ligands to DC-SIGNGregor Jug, Marko Anderluh, Tihomir TomašičJournal of Medicinal Chemistry|February 7, 2020
Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs)Anja Kolarič, Marko Anderluh, Nikola MinovskiMolecules (Basel, Switzerland)|March 6, 2021
Overview of the Assays to Probe <i>O</i>-Linked β-<i>N</i>-Acetylglucosamine Transferase Binding and ActivityCyril Balsollier, Roland J Pieters, Marko AnderluhDrug Discovery Today|May 23, 2020
CCK<sub>2</sub>R antagonists: from SAR to clinical trialsDoroteja Novak, Marko Anderluh, Petra Kolenc PeitlFrontiers in Pharmacology|August 7, 2025
Mechanisms of beneficial effects of DPP-4 inhibitors as a promising perspective for the prevention/treatment of the disruption of cardio-cerebrovascular homeostasisKatarina Tomović Pavlović, Marko Anderluh, Andrija ŠmelcerovićMedicinal Research Reviews|April 13, 2024
Galectin-8 inhibition and functions in immune response and tumor biologyEdvin Purić, Ulf J Nilsson, Marko AnderluhCellular Signalling|April 6, 2010
C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunityUrban Svajger, Marko Anderluh, Matjaz Jeras, et al.Journal of Medicinal Chemistry|May 3, 2022
The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IVMaja Kokot, Marko Anderluh, Martina Hrast, et al.Pageof 9